Belinda Kingston
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 04, 2024
ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer.
Journal: Cancer discovery
Published: December 21, 2022
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA.
Journal: Nature communications
Published: July 17, 2021
Genomic profile of advanced breast cancer in circulating tumour DNA.
Journal: Nature communications
Published: June 29, 2020
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Journal: The Lancet. Oncology
Published: April 24, 2020
Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations.
Journal: JCO precision oncology
Published: October 03, 2019
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience.
Journal: Breast cancer research and treatment
Published: January 07, 2019
Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 12, 2018
Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Journal: Breast (Edinburgh, Scotland)
Published: June 12, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026